Following the results of radiation dosimetry from this study then next steps will be taken for groups 2 \& 3 using hormone manipulation.
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Participants without any known adrenal pathology as normal controls for radiation dosimetry purposes
You may not be if
Pregnancy
Unable to do imaging
Body weight greater than 400 lbs (181 Kg)
Current use of steroids, Oral contraceptives (OCP), spironolactone, estrogen, androgen, progesterone, Angiotensin-converting enzyme (ACE inhibitors)/ Angiotensin II receptor blockers (ARBs), or supplements that are hormone analogues.
Known adrenal pathology
Clareo Health | Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Group 1)
